SOMERSET, N.J., April 02, 2018 -- MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based EHR and practice management solutions, today announced that Ryan Howard, founder and former CEO of Practice Fusion, has joined MTBC as Special Advisor to the CEO. In this role, he will be providing strategic guidance to support the growth of MTBC’s next generation EHR, talkEHR.
“Ryan is an accomplished strategist and thought leader who built the largest cloud-based physician-patient platform in the United States by offering a free EHR,” said Stephen Snyder, MTBC CEO. “We share Ryan’s disruptive vision of empowering healthcare providers with a top-tier, free EHR and are thrilled that he will be helping support our continued growth.”
“I’m very pleased to join MTBC as Special Advisor to the CEO” said Howard. “Having spent much of the last decade building the largest physician-patient platform in the United States, I look forward to supporting MTBC’s full launch and growth of talkEHR.”
talkEHR is designed to utilize natural language processing and artificial intelligence to automate key components of patient charting and reduce manual tasks and errors. It is offered completely free of cost to healthcare providers. talkEHR users are also eligible to upgrade to MTBC's premium, end-to-end medical billing solution, which is offered at one of the lowest price points in the industry.
Howard, a serial entrepreneur and industry veteran, founded Practice Fusion in 2005. Under his leadership, Howard grew Practice Fusion into one of the largest physician-patient platforms in the United States. In 2016, Howard founded iBeat, a wearable technology company, which he continues to lead as CEO.
About MTBC
MTBC is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC’s common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.”
For additional information, please visit our website at www.mtbc.com.
Follow MTBC on Twitter, LinkedIn and Facebook.
SOURCE MTBC
Disclaimer:
This press release is for information purposes only, and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.
Disclaimer
Practice Fusion® is a registered trademark of Practice Fusion and its use does not imply an endorsement or approval of MTBC, its products or this press release.
Company Contact: Rachel Grossinger Marketing Manager Medical Transcription Billing, Corp. [email protected] 732-873-5133 Investor Contact: Bill Korn Chief Financial Officer Medical Transcription Billing, Corp. [email protected] 732-873-5133


BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Jetstar to Charge for Overhead Cabin Bags From February
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Telegram Restored on Apple App Store After Temporary Removal
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Apple Restores Telegram to App Store After Content Policy Violation
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover 



